Establishment of A Novel System for Malignancy Grading of Oral Cancer Using Molecular Biological Technique
Establishment of A Novel System for Malignancy Grading of Oral Cancer Using Molecular Biological Technique
批准号:
05404069
负责人:
ENOMOTO Shoji
金额:
$13.12万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1996
中文摘要
为了研究口腔鳞状细胞癌(OSCC)原发部位的肿瘤细胞和转移的肿瘤细胞之间的差异,我们尝试使用独立于患者的原发肿瘤和转移肿瘤建立细胞系。此外,还对来自同一患者的口腔粘膜的正常人角质形成细胞(NHK)进行细胞系建立,其用作理想的对照细胞。在1993-1996年成功建立的5个细胞系中,在无蛋白培养基中同时建立了口腔鳞状细胞癌(OSCC)、口腔鳞状细胞癌(NHK)和正常角质形成细胞(NK)的原代细胞系、转移细胞系和正常角质形成细胞系,用PCR方法对OSCC和NHK细胞的转录本进行了差异显示,以寻找OSCC和NHK细胞特异表达的基因。我们报道了一个蛋白质,该蛋白质在口腔鳞状细胞癌(OSCC)和NHK细胞中的表达,并与正常角质形成细胞系的表达进行了比较。一种能识别未知血管内皮细胞的单克隆抗体, 关于我们 PKC eta是已知在上皮细胞中表达的PKC的亚型。为了了解细胞的生物学行为,使用腺病毒载体在上皮细胞中过表达PKC eta。结果发现,12-O-十四烷酰佛波醇13-乙酸酯(TPA)可抑制上皮细胞的生长,而成纤维细胞在相同条件下不受抑制,提示可能的基因治疗OSCC。我们以前报道过,p53抑癌基因在OSCC中经常发生突变,并被认为与该肿瘤的发生有关。为了了解突变的作用,在口腔鳞癌中发现的p53突变体进行了检查转染试验。第138位密码子的瓦尔突变体为温度敏感突变体。为建立p53基因突变的分子诊断体系,对p53基因突变的基因状态、临床过程和组织学恶性程度进行了详细的比较。虽然p53基因突变频率很高,但我们没有发现突变的存在与临床或组织学恶性程度之间有明显的相关性,提示p53基因突变在口腔鳞癌的发生中起重要作用。少
英文摘要
To investigate the difference between tumor cells of the primary site and metastasized tumor cells of oral squamous cell carcinoma (OSCC), we tried to establish cell lines using primary and metastasized tumors independently from a patient. In addition, normal human keratinocytes (NHK) from oral mucosa of the same patient was also subjected to cell line establishment, which served as ideal control cells. In 2 out of 5 cell lines, which were successfully established between 1993-1996, the primary and metastasized tumor cell lines and normal kratinocyte cell lines were simultaneously established in the protein free media.Transcripts from OSCC and NHK cells were differentially displayd by PCR method using sets of arbitrary primers to search for genes specifically expressed in OSCC or NHK cells.We reported a protein which was expressed by one of the OSCC cell line and was found to suppress the growth of lymphocytes.In addition, a monoclonal antibody, which recognize an unknown vascular endo … More epitherial protein, were prepared.PKC eta is a subtype of the PKC is known to be expressed in the epitherial cells. To understand the cell biological behavior, PKC eta was overexpressed in the epithelial cells using an adenovirul vector. It was found that the treatment by the 12-O-tetradecanoylphorbol 13-acetate (TPA) suppressed the growth of epithelial cells, while fibroblasts were not suppressed under the same condition, suggesting a possible gene therapy of OSCC.We previously reported that p53 tumor suppressor gene is frequently mutated in OSCC,and is considered to be responsible for the development of this tumor. To know the role of the mutation, the p53 mutants found in OSCC were examined by transfection assays. A mutant with Val of codon 138 were found to be a temperature sensitive mutant. To establish a system of molecular diagnosis using the p53 gene mutations, the status of the gene, clinical process and histological malignancy grade are compared in detail. Although the mutation frequency was so high, we could not found an obvious correlation between the existence of mutation and clinical or histological malignancy grade, suggesting that the p53 mutation is important in the initiation of OSCC. Less
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Sekiguchi, T.et al.: "Apoptosis is induced in BHK cells by the tsBN462/13 mutation in CCG1/TAFII250 subunit of the TFIID basal cell trascription factor" Experimental Cell Research. 218. 490-498 (1995)
Sekiguchi, T.等人:“TFIID 基底细胞转录因子 CCG1/TAFII250 亚基中的 tsBN462/13 突变诱导 BHK 细胞凋亡”实验细胞研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yamato, K., et al.: "Temperature-sensitive p53 mutant p53Val-138 : Modulation of the cell cycle, viability and expression of p53-responsive genes" Oncogene. 11. 1-6 (1995)
Yamato, K., et al.:“温度敏感的 p53 突变体 p53Val-138:细胞周期、活力和 p53 响应基因表达的调节”Oncogene。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hirano.Y.,Yamato K,and Tsuchida N: "A temperature sensitive mutant of the human p53,valine 138 Arrests the growth without induced expression of cip.1-wafinsbi" Oncogine. 10. 1879-1885 (1995)
Hirano.Y.、Yamato K 和 Tsuchida N:“人类 p53、缬氨酸 138 的温度敏感突变体可在不诱导 cip.1-wafinsbi 表达的情况下抑制生长”致癌基因。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
平野泰正,松村耕治,酒井英紀,土田信夫: "口腔癌-臨床DNA診断" 金原出版, 3- (1995)
Yasumasa Hirano、Koji Matsumura、Hideki Sakai、Nobuo Tsuchida:“口腔癌 - 临床 DNA 诊断” Kanehara Publishing,3-(1995)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hirano.Y.,Yamatok,and Tsuchida N: "A temperature sensitive mutant of the human P53,Valiue 138 Arrests the growth without induced expression of cip・1-Wafz-sbi" Oncogine. (in perss).
Hirano.Y.、Yamatok 和 Tsuchida N:“人类 P53 的温度敏感突变体,Valiue 138 在不诱导 cip·1-Wafz-sbi 表达的情况下抑制生长”Oncogine(在 perss 中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 23 条
STUDY ON MOLECULAR DIAGNOSIS OF ORAL PREMALIGNANT LESION EXPECTED TO BE TRANSFORMED INTO SQUAMOUS CELL CARCINOMA
-
批准号:09307047
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$13.5万
-
财政年份:1997
-
负责人:ENOMOTO Shoji
-
依托单位:
Development of alveolar ridge awgmentation with active GBR
-
批准号:08557113
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$12.61万
-
财政年份:1996
-
负责人:ENOMOTO Shoji
-
依托单位:
Establishment of Mandibulor Reconstruction with Bone Merphogenetic Protein
-
批准号:05557089
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$8.32万
-
财政年份:1993
-
负责人:ENOMOTO Shoji
-
依托单位:
The Development for Osteoinductive and Biodegradable Bone Substitute Materials
-
批准号:03557086
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$7.81万
-
财政年份:1991
-
负责人:ENOMOTO Shoji
-
依托单位:
Research and Development of New Bone Substitute Using BMP with Atelocollagen
-
批准号:63870078
-
项目类别:Grant-in-Aid for Developmental Scientific Research
-
资助金额:$4.03万
-
财政年份:1988
-
负责人:ENOMOTO Shoji
-
依托单位:
An Experimental Study for the Permeability of Oral Mucosa
-
批准号:59570843
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.02万
-
财政年份:1984
-
负责人:ENOMOTO Shoji
-
依托单位: